Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Colorectal cancer screening with fecal occult blood test: A 22-year cohort study.

Jin P, Wu ZT, Li SR, Li SJ, Wang JH, Wang ZH, Lu JG, Cui XJ, Han Y, Rao J, Sheng JQ.

Oncol Lett. 2013 Aug;6(2):576-582. Epub 2013 Jun 14.

2.

The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings.

Elsafi SH, Alqahtani NI, Zakary NY, Al Zahrani EM.

Clin Exp Gastroenterol. 2015 Sep 9;8:279-84. doi: 10.2147/CEG.S86419. eCollection 2015.

3.

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.

J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. Epub 2007 Sep 25.

4.

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.

Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.

PMID:
18482589
5.

Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.

Daniels K, McKee M.

J R Army Med Corps. 1995 Oct;141(3):142-50. Erratum in: J R Army Med Corps 1996 Feb;142(1):49.

PMID:
8568748
6.

Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.

Parente F, Marino B, Ardizzoia A, Ucci G, Ilardo A, Limonta F, Villani P, Moretti R, Zucchi A, Cremaschini M, Pirola ME.

Am J Gastroenterol. 2011 Nov;106(11):1986-93. doi: 10.1038/ajg.2011.185. Epub 2011 Jun 14.

PMID:
21670773
7.

[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].

Quintero E.

Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Review. Spanish.

PMID:
19577340
8.

Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening.

Parra-Blanco A, Gimeno-García AZ, Quintero E, Nicolás D, Moreno SG, Jiménez A, Hernández-Guerra M, Carrillo-Palau M, Eishi Y, López-Bastida J.

J Gastroenterol. 2010 Jul;45(7):703-12. doi: 10.1007/s00535-010-0214-8. Epub 2010 Feb 17.

PMID:
20157748
9.

A quantitative immunochemical fecal occult blood test for colorectal neoplasia.

Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Leshno M, Niv Y.

Ann Intern Med. 2007 Feb 20;146(4):244-55.

PMID:
17310048
10.

Screening for colon cancer: A test for occult blood.

Khakimov N, Khasanova G, Ershova K, Gibadullina L, Vetkina T, Lobisheva G, Chumakova A.

Int J Risk Saf Med. 2015;27 Suppl 1:S110-1. doi: 10.3233/JRS-150712.

PMID:
26639687
11.

Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.

Hundt S, Haug U, Brenner H.

Ann Intern Med. 2009 Feb 3;150(3):162-9.

PMID:
19189905
12.
13.

Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience.

Zappa M, Castiglione G, Paci E, Grazzini G, Rubeca T, Turco P, Crocetti E, Ciatto S.

Int J Cancer. 2001 Apr 1;92(1):151-4.

14.

Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas.

Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Sakaguchi K, Shiratori Y.

Am J Gastroenterol. 2007 Oct;102(10):2259-64. Epub 2007 Jul 7.

PMID:
17617203
15.

Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.

Hughes K, Leggett B, Del Mar C, Croese J, Fairley S, Masson J, Aitken J, Clavarino A, Janda M, Stanton WR, Tong S, Newman B.

Aust N Z J Public Health. 2005 Aug;29(4):358-64.

PMID:
16222934
16.

Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study.

Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, Dassonville F, Bonithon-Kopp C.

Gastroenterology. 2004 Jun;126(7):1674-80.

PMID:
15188160
17.

Screening for colorectal cancer: current status in Japan.

Saito H.

Dis Colon Rectum. 2000 Oct;43(10 Suppl):S78-84. Review.

PMID:
11052482
18.

Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms.

Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, Birkenfeld S, Niv Y.

Aliment Pharmacol Ther. 2009 Feb 15;29(4):450-7. doi: 10.1111/j.1365-2036.2008.03898.x. Epub 2008 Nov 17.

19.

Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.

Deutekom M, van Rossum LG, van Rijn AF, Laheij RJ, Fockens P, Bossuyt PM, Dekker E, Jansen JB.

Scand J Gastroenterol. 2010 Nov;45(11):1345-9. doi: 10.3109/00365521.2010.497937. Epub 2010 Jun 21.

PMID:
20560814
20.

Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.

Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, Tichet J, Launoy G.

Gut. 2007 Feb;56(2):210-4. Epub 2006 Aug 4.

Items per page

Supplemental Content

Write to the Help Desk